Home › Funds › MPM BioImpact LLC › CNTX
MPM BioImpact LLC position in CNTX
CONTEXT THERAPEUTICS INC · Health Care
MPM BioImpact LLC reported holding 1,299,046 shares of CNTX (CONTEXT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$720K, representing 0.04% of its reported portfolio and ranking #36 among its reported holdings. MPM BioImpact LLC has disclosed CNTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MPM BioImpact LLC's CNTX position evolved
MPM BioImpact LLC first disclosed a stake in CNTX in Q4 2024 at 14,705,882 shares (US$15.4M). The position peaked in Q1 2026 at 10,679,391 shares, worth US$28.0M. Across 7 filings, MPM BioImpact LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 1,299,046 shares valued at US$720K — a reduction of -9,380,345 shares quarter over quarter.. Notable position changes include a 27% trim in Q4 2025 (shares rose 78% over the following quarter), a 88% trim in Q2 2026 (shares fell 46% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 14.71M | $15.44M | New |
| Q1 2025 | 14.71M | $9.00M | Hold |
| Q2 2025 | 14.71M | $9.64M | Hold |
| Q3 2025 | 14.71M | $14.25M | Hold |
| Q4 2025 | 10.68M | $15.70M | Reduce |
| Q1 2026 | 10.68M | $27.98M | Hold |
| Q2 2026 | 1.30M | $719.54K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CNTX and 13F data
CNTX (CONTEXT THERAPEUTICS INC) is a Health Care company. 36 other funds we track also report a position in CNTX — the largest reported positions include Nextech Invest Ltd. (US$4.1M), Avidity Partners Management LP (US$2.8M), Octagon Capital Advisors LP (US$1.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CNTX
- Nextech Invest Ltd. 7.42M sh · $4.11M · Q2 2026
- Avidity Partners Management LP 5.00M sh · $2.77M · Q2 2026
- Octagon Capital Advisors LP 3.05M sh · $1.69M · Q2 2026
- Blue Owl Capital Holdings LP 2.93M sh · $1.63M · Q2 2026
More on MPM BioImpact LLC
FAQ
How long has MPM BioImpact LLC held CNTX?
MPM BioImpact LLC has disclosed CNTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is MPM BioImpact LLC's current position in CNTX?
As of Q2 2026, MPM BioImpact LLC holds 1.30M shares of CNTX (CONTEXT THERAPEUTICS INC), valued at $719.54K, representing 0.04% of its reported portfolio and ranking #36.
Has MPM BioImpact LLC been buying or selling CNTX?
In the latest 13F filing (Q2 2026), MPM BioImpact LLC reduced its position in CNTX. The position peaked in Q1 2026 at 10.68M shares.
Which other funds hold CNTX?
Other major institutional holders of CNTX include Nextech Invest Ltd., Avidity Partners Management LP, Octagon Capital Advisors LP, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.